Intersect ENT Gets $30M
Menlo Park-based Intersect ENT, which develops sinus implants used to treat ear, nose and throat patients, said today that it has raised $30M in a Series D round of funding. The round was led by Norwest Venture Partners, and also included Kleiner Perkins Caufield & Byers, U.S. Venture Partners, PTV Sciences and Medtronic. The firm said the new funds will go towards commercialization efforts. The firm is led by Lisa Earnhardt.
posted on Monday, February 25, 2013 (Link to more information)
Related companies:
Intersect Communications
Related stories:
> Intersect ENT Adds $15.5M
silicontap.com Home